Tailored T-cells specially designed to combat a half dozen viruses are safe and may be effective in preventing and treating multiple viral infections, according to research led by Children's National Hospital faculty.
Nov 18, 2019
0
3
A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...
Mar 27, 2023
0
6
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Mar 10, 2015
0
5
The U.S. National Institutes of Health are launching an early-stage clinical trial to evaluate a potential vaccine for Epstein-Barr virus (EBV).
May 11, 2022
0
26
The Epstein-Barr virus can cause a spectrum of diseases, including a range of cancers. Emerging data now show that inhibition of a specific metabolic pathway in infected cells can diminish latent infection and therefore the ...
May 23, 2024
0
88
Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and safety in a phase II study of patients who had undergone ...
Jan 11, 2023
0
2
About 6% of people in the UK are wrongly labeled on their medical records as being allergic to penicillin, the Royal Pharmaceutical Society has warned.
Oct 5, 2023
0
30
Using a genome-wide association study, EPFL scientists have identified subtle genetic changes that can cause substantial differences to how we fight viral infections.
Oct 8, 2015
0
34
(HealthDay)—Infectious mononucleosis (IM) during childhood, particularly during adolescence, appears to be a risk factor for subsequent diagnosis of multiple sclerosis (MS), independent of shared familial factors, according ...
Oct 13, 2021
0
7
An international team of scientists including researchers at St. Jude Children's Research Hospital have identified a crucial signaling enzyme as a possible therapeutic target for the treatment of a heritable immune disease. ...
Jan 13, 2016
0
33
